These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 16979812

  • 41. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
    Spritzer PM, Comim FV, Capp E, D'Avila A.
    Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
    [Abstract] [Full Text] [Related]

  • 42. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 43. Comparison of finasteride versus flutamide in the treatment of hirsutism.
    Falsetti L, Gambera A, Legrenzi L, Iacobello C, Bugari G.
    Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
    [Abstract] [Full Text] [Related]

  • 44. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S, Carlström K, Garoff L, Glant R, Hirschberg AL.
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [Abstract] [Full Text] [Related]

  • 45. Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.
    Sayin NC, Gücer F, Balkanli-Kaplan P, Yüce MA, Ciftci S, Kücük M, Yardim T.
    J Reprod Med; 2003 Mar; 48(3):165-70. PubMed ID: 12698773
    [Abstract] [Full Text] [Related]

  • 46. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 47. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M.
    Acta Univ Palacki Olomuc Fac Med; 1989 Nov; 122():239-45. PubMed ID: 2530821
    [Abstract] [Full Text] [Related]

  • 48. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY, Baracat EC, Pardini DP, Vieira JG, de Lima GR.
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [Abstract] [Full Text] [Related]

  • 49. Clinical and biochemical characteristics of polycystic ovary syndrome in Croatian population.
    Baldani DP, Skrgatić L, Goldstajn MS, Zlopasa G, Oguić SK, Canić T, Piljek AN.
    Coll Antropol; 2012 Dec; 36(4):1413-8. PubMed ID: 23390843
    [Abstract] [Full Text] [Related]

  • 50. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 51. [The diagnostic value of serum hormone parameters in hirsutism].
    Carol W, Börner A, Wilke I, Starker W, Michels W.
    Zentralbl Gynakol; 1992 Jan; 114(10):502-8. PubMed ID: 1329402
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome.
    Guzel AI, Kuyumcuoğlu U, Celik Y.
    Arch Gynecol Obstet; 2012 Mar; 285(3):767-70. PubMed ID: 21909749
    [Abstract] [Full Text] [Related]

  • 54. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H, Rittmaster RS.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [Abstract] [Full Text] [Related]

  • 55. Assessment of androgens in women with adult-onset acne.
    Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, Firooz A, Ghodsi SZ.
    Int J Dermatol; 2007 Nov; 46(11):1188-91. PubMed ID: 17988341
    [Abstract] [Full Text] [Related]

  • 56. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 57. Hirsutism and virilism in women.
    Kirschner MA.
    Spec Top Endocrinol Metab; 1984 Feb; 6():55-93. PubMed ID: 6084314
    [Abstract] [Full Text] [Related]

  • 58. Serum resistin levels in women with polycystic ovary syndrome.
    Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D.
    Fertil Steril; 2004 Feb; 81(2):361-6. PubMed ID: 14967374
    [Abstract] [Full Text] [Related]

  • 59. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.
    Bideci A, Camurdan MO, Yeşilkaya E, Demirel F, Cinaz P.
    J Obstet Gynaecol Res; 2008 Aug; 34(4):578-84. PubMed ID: 18937712
    [Abstract] [Full Text] [Related]

  • 60. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
    Dikensoy E, Balat O, Pence S, Akcali C, Cicek H.
    Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.